DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13774-13779. doi: 10.1073/pnas.1609024113. Epub 2016 Nov 14.

Abstract

Routine dietary consumption of foods that contain aflatoxins is the second leading cause of environmental carcinogenesis worldwide. Aflatoxin-driven mutagenesis is initiated through metabolic activation of aflatoxin B1 (AFB1) to its epoxide form that reacts with N7 guanine in DNA. The resulting AFB1-N7-dG adduct undergoes either spontaneous depurination or imidazole-ring opening yielding formamidopyrimidine AFB1 (AFB1-Fapy-dG). Because this latter adduct is known to persist in human tissues and contributes to the high frequency G-to-T mutation signature associated with many hepatocellular carcinomas, we sought to establish the identity of the polymerase(s) involved in processing this lesion. Although our previous biochemical analyses demonstrated the ability of polymerase ζ (pol ζ) to incorporate an A opposite AFB1-Fapy-dG and extend from this mismatch, biological evidence supporting a unique role for this polymerase in cellular tolerance following aflatoxin exposure has not been established. Following challenge with AFB1, survival of mouse cells deficient in pol ζ (Rev3L-/-) was significantly reduced relative to Rev3L+/- cells or Rev3L-/- cells complemented through expression of the wild-type human REV3L. Furthermore, cell-cycle progression of Rev3L-/- mouse embryo fibroblasts was arrested in late S/G2 following AFB1 exposure. These Rev3L-/- cells showed an increase in replication-dependent formation of γ-H2AX foci, micronuclei, and chromosomal aberrations (chromatid breaks and radials) relative to Rev3L+/- cells. These data suggest that pol ζ is essential for processing AFB1-induced DNA adducts and that, in its absence, cells do not have an efficient backup polymerase or a repair/tolerance mechanism facilitating survival.

Keywords: aflatoxin; environmental toxins; hepatocellular carcinogenesis; mutagenesis; translesion DNA synthesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aflatoxin B1 / analogs & derivatives
  • Aflatoxin B1 / genetics
  • Aflatoxin B1 / toxicity
  • Aflatoxins / toxicity
  • Animals
  • Carcinoma, Hepatocellular / chemically induced
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Cell Survival / drug effects
  • Chromosome Aberrations / drug effects
  • Cytidine / analogs & derivatives
  • Cytidine / genetics
  • Cytidine / toxicity
  • DNA Adducts / drug effects
  • DNA Adducts / genetics
  • DNA Damage / drug effects
  • DNA Repair / genetics
  • DNA-Binding Proteins / genetics*
  • DNA-Directed DNA Polymerase / chemistry
  • DNA-Directed DNA Polymerase / genetics*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Liver Neoplasms / chemically induced
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Mice
  • Mutagenesis / drug effects
  • Mutagenesis / genetics
  • Mutation

Substances

  • 8,9-dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)-9-hydroxyaflatoxin B1
  • Aflatoxins
  • DNA Adducts
  • DNA-Binding Proteins
  • Cytidine
  • Aflatoxin B1
  • DNA polymerase zeta
  • DNA-Directed DNA Polymerase
  • REV3L protein, human
  • REV3L protein, mouse